Navigation Links
Cocaine images capture motivated attention among users
Date:4/4/2011

UPTON, NY - Scientists at the U.S. Department of Energy's Brookhaven National Laboratory and Stony Brook University (SBU) have conducted the most comprehensive study to date of how cocaine users respond to drug-related and other emotional stimuli, making use of comparisons with a matched control group and exploring the effects of recent cocaine use and abstinence. The findings appear in a paper published online in the European Journal of Neuroscience.

Using measures of brain activity over time, the scientists found that images depicting cocaine use immediately captured motivated attention among both active and abstinent cocaine users - similar to the way other pleasant and unpleasant emotional images captured their attention compared with less evocative neutral scenes. But while abstinent cocaine users generally retained this heightened attentive engagement, those who had used cocaine within the past three days quickly lost their sensitivity, first to pleasant and then to drug-related and unpleasant evocative images - all within a mere 2000 milliseconds.

"Though a dampened response to drug images might appear helpful in those struggling with addiction, the impaired response to other emotional stimuli among recent cocaine users could indicate a general difficulty in sustaining motivated attention," said Rita Goldstein, director of Brookhaven's Neuropsychoimaging Group. "Impairments in sustaining non-drug-related, goal-oriented motivation could predispose addicted individuals to drug use as a way to compensate for their reduced response to other reinforcement - including the rewards that would come from not taking drugs," she said.

The scientists studied 28 people addicted to cocaine who had used the drug within the past three days, 27 addicted individuals who had not used in that time, and 29 matched healthy control subjects. Using a "cap" of electrodes placed externally on the scalp, the scientists took measures of brain activity while the subjects viewed selected pleasant, unpleasant, neutral, and drug-related images, capturing data at three time intervals - within 300 milliseconds, 400-1000 milliseconds, and 1000-2000 milliseconds after each image was shown.

"These event-related potentials (ERPs) are a direct measure of neural activity and are ideally suited to study the time-course of attentive engagement with emotional and drug-related stimuli in addiction," said SBU graduate student Jonathan Dunning, first author on the paper, who worked on this project in collaboration with Rita Goldstein and Greg Hajcak, his advisor at SBU.

The earliest measure showed that all subjects paid heighted attention to drug-related, pleasant, and unpleasant images compared to neutral ones. But in the next time interval, only the cocaine-addicted individuals (both those who were abstinent and recent users) showed a heightened response to drug-related images, continuing to respond as they did to other pleasant and unpleasant evocative images, while healthy control subjects maintained elevated responses only to the pleasant and unpleasant images.

"This increased neural response to cocaine-associated images among cocaine users is what we expected," Dunning said. "It suggests that cocaine stimuli are similar to other emotional stimuli in increasing motivated attention among cocaine users."

In the final time interval, 1000-2000 milliseconds, the scientists found that healthy controls remained responsive to pleasant and unpleasant images, while abstinent cocaine users continued to respond to pleasant and drug-related images at a heightened level. Interestingly, however, neural activity among subjects who had recently used cocaine was no longer heightened by the cocaine-related images - or by the other emotionally evocative images - compared with the neutral ones.

"This latest time interval reflects sustained processing and encoding of information," Goldstein said, "so our findings may indicate an impaired ability for sustained processing of all emotional stimuli - pleasant, unpleasant, and drug-related - among the recent cocaine users."

This difficulty in sustaining motivated attention to emotional stimuli could potentially predispose cocaine users to compulsive drug use as a compensatory mechanism for their blunted response, she said.

Given these findings, Goldstein and her SBU colleagues are interested in conducting further research to investigate whether similar event-related brain potentials can be useful in predicting behavior (e.g., drug-related choice) or even longer-term abstinence and treatment outcomes among individuals addicted to cocaine.


'/>"/>

Contact: Karen McNulty Walsh
kmcnulty@bnl.gov
631-344-8350
DOE/Brookhaven National Laboratory
Source:Eurekalert

Related medicine news :

1. UM School of Medicine finds prenatal cocaine exposure not severely damaging to growth, learning
2. As Temperatures Rise, So Do Cocaine Deaths
3. Crack and cocaine use a significant HIV risk factor for teens
4. Contaminated Cocaine Can Cause Flesh to Rot
5. Scripps Research scientists uncover previously unknown natural mechanism that controls cocaine use
6. NIH-supported finding on cocaine addiction: Tiny molecule, big promise
7. Rat Study Sheds Light on Cocaine Addiction
8. Chemical system in brain behaves differently in cocaine addicts, UT Southwestern scientists find
9. Drugs to treat cocaine abuse?
10. Experimental treatments for cocaine addiction may prevent relapse
11. Mount Sinai researchers discover why cocaine is so addictive
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Catalent Pharma Solutions, ... biologics and consumer health products, today announced that it had joined the Pharmaceutical ... a non-profit organization to unite pharmaceutical and healthcare companies that share a vision ...
(Date:12/8/2016)... ... 2016 , ... Healthcare is in flux. The GOP wants ... mass media launching of story movements to highlight what's most unfair about healthcare. ... such a movement can generate the network power to improve healthcare policies in ...
(Date:12/8/2016)... ... December 08, 2016 , ... Peter Zipp Insurance, ... and around the greater Phoenix metropolitan region, is announcing a charity event to ... of the Homeless Youth Connection is to promote community awareness of the ongoing ...
(Date:12/7/2016)... ... 07, 2016 , ... DrugDev again demonstrated its dedication to reducing ... the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department of Commerce. ... sides of the Atlantic with a mechanism to comply with EU data protection requirements ...
(Date:12/7/2016)... ... December 07, 2016 , ... Silhouette Instalift is ... by smoothing and tightening the skin of the face to create more youthful ... aging with very little downtime, Silhouette Instalift is a novel, minimally invasive facial ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  Valeant Pharmaceuticals International, Inc. ... ("Valeant") today announced positive results from a Phase ... assess the safety and efficacy of IDP-118 (halobetasol ... plaque psoriasis. Within the Phase ... to severe psoriasis, IDP-118 showed statistical significance to ...
(Date:12/8/2016)... -- Mederi Therapeutics Inc . hat die behördliche Zulassung durch die ... Refluxerkrankung (GERD) – in China angekündigt. ... ... Live Stretta procedure performed and broadcast during the ... at Wuhan Union Hospital ...
(Date:12/8/2016)...  Boehringer Ingelheim announced today that it has been ... is the ninth time that the company received a ... Place to Work for LGBT Equality. Administered by the ... benchmarking report on corporate policies and practices related to ... employees. "We are committed to creating ...
Breaking Medicine Technology: